Drug Trial Radar · NCT02517021
A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting
Last checked: Nov 20, 2026Latest source record: Jun 20, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
405
Actual
Start
Nov 2015
Primary completion
Aug 2016
Study completion Aug 2016
Sponsor
- Lead sponsor
- Helsinn Healthcare SAIndustry
- Sponsor type
- Industry
- Collaborators
- PSI CRO
- First posted
- Aug 6, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
NEPA-15-18 is a clinical study assessing safety of pro-netupitant and palonosetron, two antiemetic drugs, given with oral dexamethasone. The objective of the study is to evaluate if pro-netupitant and palonosetron are safe when administered to prevent nausea and vomiting after administration of repeated cycles of chemotherapy.
Conditions
- Chemotherapy-Induced Nausea and Vomiting
Interventions
Pro-netupitant/PalonosetronDrug
Netupitant/PalonosetronDrug
DexamethasoneDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Patients With Adverse EventsTime frame: Participants will be followed for the duration of the chemotherapy, an expected average duration of up to 14 weeks assuming a maximum of 4 chemotherapy cycles given every 3 weeks.
Locations
74 sites in 12 countries. Site status is shown where the registry gives one.
Sarcoma Oncology Center
Santa Monica, California
The Oncology Institute of Hope and Innovation
Whittier, California
St. Mary's Medical Center
Grand Junction, Colorado
Well Pharma Medical Research Corporation
Miami, Florida
Illinois CancerCare
Peoria, Illinois
Indiana University Health Bloomington
Bloomington, Indiana
Christus St. Frances Cabrini Hospital
Alexandria, Louisiana
North Shore Hematology Oncology Associates PC
East Setauket, New York
Gabrail Cancer Center Research
Canton, Ohio
West Cancer Center
Germantown, Tennessee
Provision Center for Biomedical Research
Knoxville, Tennessee
University Hospital Graz, Department of Internal Medicine
Graz, Austria
Krems Country Hospital
Krems, Austria
Hospital Elisabethinen Linz GmbH, Internal Department #1 - Hemato-Oncology
Linz, Austria
General Hospital Linz GmbH, Internal Medicine Department #3 - Center for Hematology and Medical Oncology
Linz, Austria
University Hospital St. Poelten,1st Medical Department
Sankt Pölten, Austria
Clinical Hospital Centre Osijek
Osijek, Croatia
General Hospital Varazdin
Varaždin, Croatia
Clinical Hospital Center "Sestre milosrdnice"
Zagreb, Croatia
University Hospital Centre Zagreb "Jordanovac"
Zagreb, Croatia
University Hospital Brno. Clinic of Pulmonary Diseases and Tuberculosis
Brno, Czechia
University Hospital
Brno, Czechia
Hospital Novy Jicin, Department of Oncology
Nový Jičín, Czechia
Thomayer's Hospital, Clinic of Pneumology
Prague, Czechia
Hospital Na Bulovce
Prague, Czechia
Masaryk's Hospital Usti nad Labem, Oncology Dept
Ústí nad Labem, Czechia
Onkoligische Schwerpunktpraxis Bielefeld
Bielefeld, Germany
OncoResearch Lerchenfeld GmbH
Hamburg, Germany
Hannover Medical School
Hanover, Germany
Universitaetsklinikum Leipzig; Universitaeres Krebszentrum (UCCL)
Leipzig, Germany
Staedtisches Klinikum Muenchen GmbH; Klinikum N euperlach
München, Germany
Barziali Medical Center, Oncology Unit
Ashkelon, Israel
Soroka University Medical Center,Oncology division
Beersheba, Israel
Rambam Health Care Campus
Haifa, Israel
S. G. Moscati Hospital, Medical Oncology Division
Avellino, Italy
cientific Institute of Romagna for the Study and Treatment of Cancer (IRST), IRCCS
Meldola, Italy
National Cancer Institute, IRCCS, Medical Oncology Department
Milan, Italy
Azienda Socio Sanitaria Territoriale-Monza (ASST-Monza) - Oncology Department
Monza, Italy
Regional Hospital "San Carlo"
Potenza, Italy
Local Healthcare Company of Vimercate (ASST Vimercate)
Vimercate, Italy
Showing 40 of 74 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.